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ABSTRACT
Objective: To assess the current scientific literature on the prevalence of hepatitis C and associated risks in 
prisons. Method: This is an integrative review conducted in the Web of Science, Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) and Literature in the Health Sciences in Latin America and the 
Caribbean (LILACS in Portuguese) databases, including articles published between 2009 and 2014. Based on 
the inclusion and exclusion criteria, we selected 16 articles. Results: Descriptive (37.5%) and transverse (50%) 
articles predominated. All of them had level IV of scientific evidence. The prevalence of Hepatitis C was varied 
and the main risk factors associated with positive results for hepatitis C were injecting drug use, tattooing 
and age. Conclusion: Being a long-haul asymptomatic disease, hepatitis C is revealed as a major problem in 
the prison system, requiring more attention in order to produce knowledge to guide the adoption of effective 
measures for control and prevention. 
Descriptors: Hepatitis C; Prevalence; Prisons; Risk factors.
RESUMO
Objetivo: Conhecer a produção científica atual sobre a prevalência de hepatite C e riscos associados nos presídios. Métodos: Trata-se 
de uma revisão integrativa realizada nas bases de dados Web of Science, Cumulative Index of Nursing and Allied Health (CINAHL) e 
Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), incluindo estudos nacionais e internacionais publicados entre 
2009 a 2014. A partir dos critérios de inclusão e exclusão, foram selecionados 16 artigos. Resultados: Predominaram os artigos descritivos 
(37,5%), transversais (50%). Todos apresentaram nível IV de evidência científica. A prevalência de hepatite C foi variada, e os principais 
fatores de risco associados à positividade para hepatite C foram o uso de drogas injetáveis, presença de tatuagem, idade. Conclusão: Por 
ser uma doença de longo curso assintomático, a hepatite C apresenta-se como um problema relevante no sistema prisional, exigindo mais 
atenção no sentido de produzir conhecimentos, que orientem a adoção de medidas efetivas de controle e prevenção. 
Descritores: Hepatite C, Prevalência, Prisões, Fatores de risco.
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RESUMEN
Objetivo: Evaluar la literatura científica actual sobre la prevalencia de la 
hepatitis C y los riesgos asociados en las cárceles y publicado en la literatura 
científica. Métodos: Se trata de una revisión integradora realizada en la base 
de datos Web of Science, CINAHL y Lilacs, incluyendo artículos publicados 
entre 2009 y 2014. Sobre la base de los criterios de inclusión y exclusión, se 
seleccionaron 16 artículos. Resultados: Artículos predominantes descriptivos 
(37,5%), transversales (50%). Todos tenían niveles IV de evidencia científica. 
La prevalencia de la hepatitis C se varió y los principales factores de riesgo 
asociados fueron consumo de drogas intravenosas, los tatuajes, la edad. 
Conclusión: Al ser una enfermedad asintomática de largo recorrido, la 
hepatitis C se revela como un problema en el sistema penitenciario, lo que 
requiere más atención con el fin de producir conocimiento para guiar la 
adopción de medidas eficaces de control y prevención. 
Descriptores: Hepatitis C, Prevalencia, Prisiones, Factores de riesgo.
INTRODUCTION
Hepatitis C has been recognized as one of the leading 
causes of chronic liver disease worldwide. The complexity 
and uncertainty related to the geographical distribution of 
hepatitis C infection, determination of associated risk factors, 
and evaluation of co-factors that accelerate its progression 
underscore the difficulties encountered for the prevention 
and control of HCV. 
Hepatitis C represents one of the greatest problems for 
the world public health due to its severity and high rate of 
chronicity. It can progress to chronic liver disease, cirrhosis 
and even hepatocarcinoma, characterizing itself as the major 
cause of death among all types of hepatitis.1 An estimated 
170 million people (3% of the world’s population) are 
infected and more than 350,000 people die each year from 
liver diseases related to hepatitis C.2-3
It is an inflammation of the liver, caused by the HCV virus, 
which belongs to the family Flaviviridae, genus Hepacavirus. 
Its genome consists of a single strand of RNA with about 
9600 nucleotides. There are 6 HCV genotypes (from 1 to 
6) and many subtypes (a, b, c, etc.) and approximately 100 
different chains, based on the heterogeneity of virus genome 
sequences. The frequency of different genotypes varies from 
country to country. Genotypes 1, 2 and 3 have worldwide 
distribution, but their relative prevalence varies from one 
geographical area to another.4 
The hepatitis C virus can be transmitted by direct, 
percutaneous, or contaminated blood. Some populations at 
risk, such as drug users, persons undergoing hemodialysis, 
transplanted patients, and incarcerated populations 
present higher prevalence when compared to the general 
population, due to a higher exposure to the risk factors 
related to Hepatitis C.5
The major risk factors for hepatitis C are blood 
transfusion and blood components from unproven donors 
to anti-HCV, organ transplants from infected donors, 
injecting drug use, injectable therapies with contaminated 
(or unsafe) equipment, hemodialysis; occupational exposure 
to blood, perinatal transmission, and sexual transmission. 
The recognition of the prevalence pattern of hepatitis C in 
the different regions may allow a greater effectiveness of 
measures for the detection and control of HCV infection.6 
Studies justify the different vulnerabilities to the disease in 
the different segments of the population.
The prison population is at high risk of contracting 
infections that are related to conditions of confinement, 
including viral hepatitis. The impact of HCV infection 
is not limited only to prison populations, which are 
often neglected and require specific approaches to the 
epidemiological profile. Populations deprived of liberty 
are characterized by marginalization and use of drugs, 
particularly illicit drugs. These characteristics, coupled 
with precarious conditions of confinement, including 
overcrowding, result in a high prevalence of infectious and 
contagious diseases such as hepatitis C.2
Incarcerated individuals are particularly affected since 
they are at greater risk of being infected due to the use of 
tattooing, piercing and injecting drug use. In addition, 
low levels of schooling, lack of knowledge about hepatitis 
C, large numbers and long periods of imprisonment are 
factors associated with increased occurrence of infection.7
In order to contribute to this discussion, the present study 
had as objective to know the current scientific production 
on the prevalence of hepatitis C and associated risks in the 
national and international prisons, through an integrative 
review of the literature. 
METHOD
It is an integrative review of the literature, carried 
out according to the six operational steps: problem 
identification; guiding question; establishment of inclusion 
and exclusion criteria; collection of data on scientific 
bases; selection of articles; analysis and interpretation 
of results. This method allows the synthesis of multiple 
published studies and allows general conclusions regarding 
a particular area of research.8
To guide the integrative review, the following question 
was asked: what are the scientific outputs on the prevalence 
of hepatitis C and associated factors in prisons?
The bibliographic survey was carried out in three 
databases: Web of Science, CINAHL (Cumulative Index to 
Nursing and Allied Health Literature) and LILACS (Latin 
American and Caribbean Literature on Health Science), in 
the months of August to November 2014. For the survey of 
the articles, the descriptors used were: prevalence, hepatitis 
C and prisons. The cross-referencing of the descriptors 
in the mentioned bases was performed via the boolean 
operator AND.
The criteria used for the selection of the sample were: 
articles published in Portuguese, English and Spanish, 
from 2009 to 2014, with complete texts available, free of 
charge in the aforementioned databases, original articles 
and dealing with the prevalence of hepatitis C and risks 
in prisons. Articles published in other languages, repeated 
in the databases and/or that did not address the proposed 
theme and review studies were excluded.
In the Web of Science database using the descriptors 
prevalence, hepatitis C and prisons, 117 articles were found 
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and, after application of the inclusion criteria, 12 were selected. In the CINAHL database, using the same descriptors, 18 
articles were found and 4 were selected. After in-depth reading, only two met the inclusion criteria, but one was repeated 
at the other base. In the end, there was only one article for sample composition. In LILACS, using the same descriptors and 
without any type of refining, seven studies were found and three were selected for the study. The final sample consisted, 
therefore, of 16 articles.
After the electronic search procedure in the mentioned databases, the publications were pre-selected based on the 
reading of the title and abstract. Subsequently, the articles were selected in full. For the data collection of the articles that 
were included, an instrument was elaborated, based on the analysis dimensions suggested by Broome9, which includes the 
following items: authorship, year of publication, title, type of study, objectives, sample, data treatment, results, conclusions 
and level of evidence. 
The selected studies were classified at the level IV of evidence according to Stetler et al.10 This level includes non-experimental 
studies: descriptive, correlational and comparative research, qualitative research and case studies. The articles that composed 
the final sample of this integrative review were typed in the instrument elaborated, analyzed through descriptive statistics and 
presented as a table.
RESULTS AND DISCUSSION
Table 1 summarizes the information provided by the articles that were included in the literature review.
Table 1 – Distribution of articles on hepatitis C and associated risks in prisons according to author/database/year of publication, 
sample/ lace of study, objectives, type of study/level of evidence and main findings.
Author/
Database/Year 
of Publication
Place of 
study Objetives Type of Study / Sample /Level of Evidence and main findings
Miller ER, Bi P, 
Ryan P. / Web of 
science/ 2009
662 / South 
Australia
To determine 
seroprevalence 
of antibodies and 
seroconversion to 
hepatitis C virus (HCV) 
and associated risk 
factors in incarcerated 
newborns.
Descriptive / IV – (n=662) 
HCV seroprevalence was estimated at 42%. The significant risk 
factor was drug use. High seroprevalence, especially in women, 
indigenous people and drug users. Increased frequency of drug 
use among those already infected with HCV poses a significant 
threat to other prisoners and prison staff.
Viitanen P, 
Vartiainen H, 
Aarnio J, von 
Gruenewaldt 
V, Hakamäki 
S, Lintonen T, 
et al. / Web of 
science/ 2011
Finland
To study the prevalence 
of hepatitis and HIV 
infections and risk factors 
among prisoners in 
Finland
Descriptive / IV – (n=388) 
Among women, HCV was only associated with IDU and syringe/
needle sharing. Among men there was also association with the 
presence of tattoos, cumulative years in prison and age. Young 
female had a high prevalence of HCV. The study showed that risk 
factors are differentiated by sex.
Teutsch S, 
Luciani F, 
Scheuer N, 
McCredie L, 
Hosseiny P, 
Rawlinson W, 
et al../ Web of 
science/ 2010
 New South 
Wales, 
Australia
To determine the HCV 
incidence among 
injecting drug users 
and conduct a detailed 
examination of the 
demographic and 
behavioral risk factors 
associated with HCV 
transmission.
Prospective cohort study /IV – (n=488)
There were 94 cases of HCV (incidence of 31.6 per 100 persons-
year). Independent associations between incident infection and 
previous arrest, tattooing, and also with methadone maintenance 
treatment (MMT) were observed. High rates of re-infection by 
HCV were found in this study reflecting the substantive risk 
related to behavior.
Brandolini M, 
Novati S, Silvestri 
A, Tinelli C, 
Patruno SFA, 
Ranieri R. et al../ 
Web of science/
2013
Milan, Italy
To assess the prevalence 
of HCV infection among 
prisoners and their 
correlated epidemiology 
and to test the feasibility 
of a screening program 
for HCV infection in 
an Italian prison and 
to evaluate treatment 
outcomes.
Cross-sectional study / IV – (n=695)
HCV seroprevalence was 22.4%. This study indicates that the 
proportion of patients in a prison setting receiving diagnosis and 
treatment for HCV infection remained low. The weight of HCV 
infection among HIV positive patients is troubling, as they often 
cannot be treated due to severe immunosuppression and share 
the worst prognosis.
Taylor A, Munro 
A, Allen E, 
Dunleavy K, 
Cameron S, Miller 
L. et al./ Web of 
science/ 2013
Scotland
To estimate the incidence 
of hepatitis C virus (HCV) 
and risk among Scottish 
prisoners.
Cross-sectional study / IV – (n= 5.076)
The overall prevalence of antibodies to HCV was 19% (933 out of 
4904). The low incidence of HCV infections in Scottish prisons 
is due to the low occurrence of injecting drug use in prison and 
high coverage of opioid substitution treatment.
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Author/
Database/Year 
of Publication
Place of 
study Objetives Type of Study / Sample /Level of Evidence and main findings
Luciani F, 
Bretaña NA, 
Teutsch S, Amin 
J, Topp L, Dore 
GJ, et al./ Web 
of science/ 2014
 New South 
Wales, 
Australia
To examine the incidence 
of HCV infection and 
associated risk behaviors 
among prospectively 
followed individuals.
Prospective cohort study / IV – (n=210)
Almost half of the cohort reported injecting drug use during 
follow-up (103 subjects, 49.1%) and 65 (31%) also reported 
injecting sharing. The estimated incidence was 14.08 per 100. 
Three subjects were RNA-positive and negative for antibodies 
at the time, indicating early infection, which provided a second 
estimate of incidence of 9.4%.
Hoya PSde la, 
Marco A, García-
Guerrero J. / 
Web of science/ 
2011
Spain
To determine the 
prevalence of factors 
associated with hepatitis 
C virus (HCV) and 
B (HBV) in Spanish 
prisoners.
Cross-sectional study / IV – (n= 378)
The prevalence of HCV infection was 22.7% (n = 84) and 40.5% 
of patients with HCV were co-infected with HIV, 0.3% with HBV, 
and 1.5% with triple-virus co-infection (HBV + HCV + HIV). The 
HCV population had a history of injecting drug use (IDU, 23.2%) 
in prison <5 years (71.2%).
Kirwa P, Evans B, 
Brant L/ Web of 
science/ 2011
England
To describe the 
characteristics of 
prisoners tested for anti-
HCV and associated risk 
factors, trends over time.
Descriptive / IV - (n=10.723)
In general, 24.2% prisoners tested positive for anti-HCV 
antibodies. Injection drug use was the most frequently reported 
risk exposure (180/186, 96.8%); Of these, 31 (of 137, 22.6%) 
prisoners were reported to be current IDUs and 106 (77.4%) 
ex-IDUs.
Burek V, Horvat 
J, Butorac K, 
Mikulic R../ Web 
of science/ 2010
The survey 
was 
conducted in 
20 prisons in 
Croatia
To determine the 
structure of the 
prison population, the 
prevalence of HBV, 
HCV, HIV markers, 
co-infections with HBV, 
HCV and HIV and acute 
by HBV, HCV and HIV 
infection.
Descriptive / IV – (n=3.348)
In total, 25.9% of prisoners were positive for some markers for 
viral hepatitis. The prevalence of HCV was 8.3%. HCV infection 
in IDUs was 52.0% and 4.9% in the highly promiscuous group. 
HBV/HCV co-infection was recorded in 34.9% of HBV-positive 
prisoners (203/582). Acute HCV infection was detected in 
1.2%. It appears that individuals with psychiatric disorders and 
personality disorders could be an additional risk population for 
viral infections.
Barros LAS, 
Pessoni GC, Teles 
SA, Souza SMB 
de, Matos MA 
de, Martins RMB, 
et al../ Web of 
science/
2013
 Goiás, Brazil
To investigate the 
prevalence and risk 
factors associated with 
infection by HBV and 
HCV and to identify 
genotypes of these 
viruses circulating in 
female prisoners of 
Goiás, Brazil.
Cross-sectional study / IV (n= 148)
Nine arresters were anti-HCV positive by ELISA and were 
confirmed by immunoblot. Five of the nine anti-HCV positive 
samples were also RNA-HCV positive. These samples were from 
genotype 1, subtypes 1a (n = 3) and 1b (n = 1), and genotype 3, 
subtype 3 (n = 1). Thus, the circulating genotypes in prisoners 
of Goiás reflect the diversity of this virus. The association of age 
with HCV was evident among women> 40 years.
Santos BFO, 
Santana NO, 
Franca AVC./ 
Web of science/ 
2011
Sergipe, Brazil
To determine the 
seroprevalence of 
hepatitis C virus (HCV) 
and its genotypes 
and to identify factors 
associated with HCV 
infection.
Cross-sectional study / IV – (n= 422)
The seroprevalence for HCV was 3.1%. Of the 13 subjects with 
anti-HCV positive, 11 had confirmed viremia by PCR. Of these, 
90.9% had genotype 1. A total of 43 (10.2%) were injecting drug 
users, and the seroprevalence of HCV in this subgroup was 20.6. 
There was an association between positive HCV and injecting 
drug use. Age above 30 years, history of syphilis and history of 
home contact with positive HCV.
Falquetto TC, 
Endringer DC, 
Andrade TU, 
Lenz D. / Web of 
science/ 2013
 Espírito 
Santo, Brazil
To compare the 
prevalence of hepatitis 
C, genotypes, and risk 
factors among prisoners 
and non-prisoners in the 
city of Colatina, Espírito 
Santo, Brazil.
Cross-sectional study / IV (n= 2.230)
In the prison population, the prevalence of positive HCV 
RNA was 0.8% (6/730), and for anti-HCV it was 1.0% (7/730). 
Diagnosis of hepatitis was strongly associated with males 
(77.7%), monthly income less than three minimum wages 
(100.0%) and low educational level (77.8%, with four years of 
schooling or less).
Larney S, 
Mahowald 
MK, Scharff N, 
Flanigan TP, 
Beckwith CG, 
Zaller ND. / 
CINAHL/ 2014
Pennsylvania, 
USA
To describe the hepatitis 
C virus (anti-HCV) 
antibody positivity in 
a Pennsylvania state 
prison system and to 
retrospectively assess 
case detection in the 
population born between 
1945-1965.
Descriptive / IV – (n= 101.727)
Prevalence of anti-HCV among 101727 adults in prison was 18.1%. 
Prevalence was almost twice as high among women (31.3%) 
compared to men (16.8%).
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Author/
Database/Year 
of Publication
Place of 
study Objetives Type of Study / Sample /Level of Evidence and main findings
Pompilio MA, 
Pontes ERJC, 
Castro ARCM, 
Andrade SMO, 
Stief ACF, 
Martins RMB. et 
al. / LILACS/ 2011
Mato Grosso 
do Sul, Brazil.
Estimate the prevalence 
of HCV, as well as identify 
factors associated 
with infection among 
prisoners.
Cross-sectional study / IV – (n= 686)
The seroprevalence of HCV infection was 4.8%. In addition, 
the prevalence was higher in men, injecting drug users, 
tattooed people, those over 50 years of age, individuals who 
were arrested multiple times, people with a prior history of 
sexually transmitted disease (STD), people who received blood 
transfusions or those with HIV/AIDS.
Coelho HC, 
Oliveira SAN 
de, Miguel JC, 
Oliveira MLA, 
Figueiredo JFC, 
Perdoná GC, 
et al./ LILACS/ 
2009
Ribeirão 
Preto, São 
Paulo, Brazil
To estimate the 
prevalence of HCV 
infection and to evaluate 
risk factors for this 
exposure among male 
prisoners in Ribeirão 
Preto.
Cross-sectional study / IV – (n= 333)
The prevalence of HCV infection among prisoners was 8.7%. 
With predominance among individuals over 30 years of age. The 
variables that were independently associated with HCV infection 
were: age> 30 years, tattooing, previous history of hepatitis, use 
of drugs without sharing syringes, and use of syringe-sharing 
drugs. The results of this study and other studies conducted 
in recent years indicate that the prevalence of HCV among 
prisoners in Brazil appears to be declining.
Rosa F, Carneiro 
M, Duro LN, 
Valim ARM, 
Reuter CP, 
Burgos MS, et al. 
/ LILACS/ 2012
 Santa Cruz 
do Sul, Rio 
Grande do 
Sul, Brazil
To estimate the 
prevalence of HCV by 
means of a rapid test in 
a prison group from the 
interior of Rio Grande do 
Sul, as well as to identify 
the epidemiological 
characteristics of the 
HCV infection.
Descriptive / IV – ( n= 195)
A total of 9.7% was HPV reagent. In this analysis, the variable 
that proved to be a predictor for HCV infection was the use of 
injectable drugs.
Source: Web of Science, CINAHL, LILACS Databases.
Of the 16 articles included in the review, the number 
of participants involved in the studies varied from 148 to 
101727. Through the analysis, it was verified that the majority 
were from the Web of Science database (75%) and that five of 
them addressed aspects studied in Brazil (31.2%).
According to Table 1, most of the studies selected were 
descriptive (37.5%) or transverse (50%), all of them presented 
level IV of scientific evidence. It can also be observed that the 
prevalence of Hepatitis C was widely varied in several studies 
and that the main risk factors associated with positive results 
for hepatitis C were the presence of tattoos and injecting 
drug users.
Considering the articles analyzed, there was a 
significant variation related to the prevalence of Hepatitis 
C in prisons. The lowest prevalence was found in the study 
conducted in the city of Colatina, Espírito Santo, among 
all study participants, the prevalence of HCV was 0.4% 
(09/2,330), and positive RNA-HCV was 0.3% (08/2,330), 
with the highest frequencies observed for genotypes 1 
(87.5%) and 3 (12.5%). In the prison population, the 
prevalence of positive HCV-RNA was 0.8% (6/730), and 
for anti-HCV was 1.0% (7/730). In the non-incarcerated 
population, the prevalence of HCV-RNA and anti-HCV 
was 0.1% (2/1600).11 However, the study conducted in 
Finland with 88 women and 300 men showed a high 
prevalence of antibodies against HCV, 52% in the groups. 
Among females, 71% and males, 43.9%.12
The incidence of HCV in the Brazilian population 
is approximately 1.5%. A study in São Paulo found a 
prevalence of 16.2% for hepatitis C in woman prisoners, 
to identify aspects associated with transmission within 
the prisons.13 The justification for the positive serological 
markers of hepatitis C among the victims is probably due 
to the sexual risk behavior, tattoos, piercings and previous 
history of intravenous drug use, which are frequent in 
this population.2
HCV is a virus that can be transmitted by direct, 
percutaneous, or contaminated blood. In this perspective, 
injecting drug users (IDUs) are the main interest group for 
the prevention of their transmission within prisons, since 
most of these users have already been arrested at some point 
in their lives. Similar data was found between researchers14 
in which more than half and up to 90% of drug users have 
ever had an episode of incarceration. 
The increased risk of positive HCV results in IDU-
related prisons was identified in a randomized clinical 
trial of 1,325 in-jail drug users conducted in Australia. 
The study found that the majority were males (77.0%), 
with an average time since the onset of injecting drug use 
of 16 years. The vast majority (86.7%) had been arrested 
previously, and the use of drugs in prison was reported 
by 285 participants (39.2%). The prevalence of HCV 
among the individuals tested was 47.4%.15 Regarding the 
association of Hepatitis C with the use of injecting drugs in 
the incarcerated population, this finding was in agreement 
with another investigation in which the prevalence of HCV 
was 80%.16
The study carried out at the philanthropic, private and 
public drug treatment centers of Goiânia (GO) and Campo 
Grande (MS), with a sample of 691 users, of which 102 were 
IDUs and 589 non-injecting drug users ( NIDU). Prevalence 
of HCV infection was of 6.9% and injecting drug use was the 
main risk factor for this infection. IDUs had a higher chance 
of HCV infection when compared to NIDU. In addition, the 
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prevalence of this infection was almost 12 times higher in the 
first group than in the second (31.4% versus 2.7%). This fact 
characterizes injecting drug users as important carriers and 
potential disseminators of HCV.17 
Other risk factors such as the presence of tattoos, age, 
blood transfusion and risky sexual practices were identified 
in some studies.7,12,8 In a study carried out in Mato Grosso 
do Sul prisons, with 443 men and 243 women, the 
seroprevalence of HCV infection was 4.8%, with a higher 
prevalence among men, injecting drug users, tattooed 
people, those with more than 50 year-old individuals who 
were arrested several times, people with previous history 
of sexually transmitted disease (STD), people who received 
blood transfusions or those with HIV/AIDS.7
HCV infection is primarily acquired parenterally 
through transfusion of infected blood, rupture of the skin 
or mucosal continuity, through infected medical equipment, 
injecting drug use, hemodialysis, or transplanted organs.6 It 
is emphasized that intrauterine transmission is uncommon. 
In relation to age, the study that identified the prevalence 
of HCV in adult users of the public health service in a 
municipality of the Paraná1 revealed that the highest 
prevalence of positive cases is found in the intermediate age 
groups, mainly between the ages of 30 and 49 years. 
Among non-parenteral forms of hepatitis C 
transmission, it is important to emphasize the possibility of 
sexual transmission. Most studies show that the chances of 
transmission are low or almost nil, ranging from 0% to 3%. 
In-home transmission is strongly considered and mentioned 
as a confounding factor when it is related to transmission 
between couples, as sharing of personal hygiene items such 
as razors, toothbrushes, manicure pliers and nail clippers 
should be considered as a significant risk factor for the 
transmission of HCV within the household19 and the sharing 
of these materials within the prison may be associated as 
predictor behavior, but no studies have been found related to 
these specific risks within prisons.
It should be noted that a study conducted in Passos, 
Minas Gerais, with the objective of analyzing risk behaviors 
in 185 prisoners, despite not having identified a positive case 
for HCV, found that the majority of detainees had a high 
prevalence of risk factors, making them more vulnerable to 
contamination. These factors included unprotected sexual 
practices, drug use, tattooing and needle sharing within the 
prison.20
HCV is transmitted more efficiently parenterally due to 
high or repeated exposure to blood and its infected products 
or transplantation of infected tissue or organs. Thus, the risks 
are greater for intravenous drug users, people with tattoos 
and piercings or who have had other forms of skin exposure 
and also individuals who received blood transfusion before 
1993. HCV is believed to be the major responsible for 
cirrhosis and liver transplantation.21 
The relative mutability of the HCV genome has been 
blamed for its high propensity to cause chronic infection. 
About 80% of new infections progress to chronic infection, 
with cirrhosis developing by about 20% after 20 to 30 years, 
resulting in increased risk of complications related to liver 
and hepatocarcinoma. The high mutability of the HCV 
genome and limited knowledge on the protective immune 
response after infection have hindered progress in vaccine 
development. For this reason, there is as yet no vaccine 
available against hepatitis C virus.22
In view of the above, it is noticed that the prevalence 
rates of HCV in prisons are higher than in the community. 
This is due to limited access to supplies such as nail 
clippers, shavers, condoms, and risky practices such as 
non-sterile tattoos and piercings, as well as homosexual 
sexual practices, sexual assault and non-injectable and 
injectable drug sharing.5
Prisoners tend to import into the prison the behavior 
pattern outside the prison, hence the importance of 
screening at the entrance to the prison, so as to provide 
adequate clinical guidance for all those infected with the 
Hepatitis C virus. Due to the lack of vaccine or effective 
post-exposure prophylaxis, the main focus of hepatitis C 
prevention is on the recognition and control of these risk 
factors.
CONCLUSION
The selected studies evidenced a wide variation in the 
prevalence of hepatitis C depending on the population 
studied, with predominance of injecting drug users; with a 
history of blood transfusion; presence of tattoo; age between 
30 and 69 years and previous history of STD . The level of 
evidence of the articles was related to the cross - sectional 
and descriptive studies, identifying knowledge gaps in the 
direction of the production of research of better scientific 
evidence as the production of randomized clinical trials.
Although the understanding of the dynamics of 
transmission of infectious diseases among prisoners 
is fundamental to guiding preventive programs, it is 
noteworthy the low scientific production of epidemiological 
studies in our country related to this population. Because it is 
an asymptomatic long-term disease, which hinders its early 
diagnosis, hepatitis C proves to be a relevant problem in the 
Brazilian prison system, requiring more attention in order 
to produce knowledge that guides the adoption of effective 
measures of control and prevention.
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